Whereas, in the established subcutaneous transplantation tumor model, IL-17 also exhibits anti-tumor activities by enhancing NK cell and CTL cell activation and by recruiting neutrophil, NK cell, CD4+, and CD8+ T cell into the TME. The gene discussed is CD8A; the disease is neoplasm.